Problems in pharmacoeconomic analyses - Reply

被引：0

作者：

Rennie, D ^{[1
]}

Luft, HS ^{[1
]}

机构：

[1] Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2000年 / 284卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1924 / 1924

页数：1

共 50 条

[31] Pharmacoeconomic analyses - Making them transparent, making them credible
Rennie, D
Luft, HS
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (16): : 2158 - 2160
[32] The role of government and private insurers in guiding and implementing pharmacoeconomic analyses
Freund, DA
Luce, BR
PHARMACOECONOMICS, 1998, 13 (04) : 383 - 387
[33] Using healthcare claims data for outcomes research and pharmacoeconomic analyses
Birnbaum, HG
Cremieux, PY
Greenberg, PE
LeLorier, J
Ostrander, J
Venditti, L
PHARMACOECONOMICS, 1999, 16 (01) : 1 - 8
[34] The Role of Government and Private Insurers in Guiding and Implementing Pharmacoeconomic Analyses
Deborah A. Freund
Bryan R. Luce
PharmacoEconomics, 1998, 13 : 383 - 387
[35] HOW MUCH FAITH CAN WE HAVE IN PHARMACOECONOMIC ANALYSES
HATOUM, HT
KONG, SX
PHARMACOECONOMICS, 1994, 6 (06) : 584 - 585
[36] Reply to: Problems with two recent Petri net analyses of Neanderthal adhesive technology
Fajardo, Sebastian
Kozowyk, Paul R. B.
Langejans, Geeske H. J.
SCIENTIFIC REPORTS, 2024, 14 (01):
[37] How to use decision analysis to solve pharmacoeconomic problems
Basskin, L
FORMULARY, 1997, 32 (06) : 619 - &
[38] The time inconsistency of decisions in pharmacoeconomic sequential decision problems
Jakubczyk, MK
Kowalik, E
Niewada, MP
VALUE IN HEALTH, 2003, 6 (06) : 801 - 801
[39] A Model to Transfer Trial-Based Pharmacoeconomic Analyses to Clinical Practice
Afschin Gandjour
PharmacoEconomics, 2011, 29 : 97 - 105
[40] A Model to Transfer Trial-Based Pharmacoeconomic Analyses to Clinical Practice
Gandjour, Afschin
PHARMACOECONOMICS, 2011, 29 (02) : 97 - 105

← 1 2 3 4 5 →